Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.3088
-0.0162 (-4.98%)
Oct 15, 2026, 4:13 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 10.67 million as of October 15, 2026. It is the 39,106th most valuable company in the world and the 852nd biggest in the United Kingdom. Its market cap has decreased by 55.04% in one year.
Market Cap
10.67M
Enterprise Value
6.48M
Revenue
1.54M
Global Rank
Country Rank
#852 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 10.67M, a decrease of -89.06%. That is a compound annual growth rate of -36.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 10.67M | -63.20% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IXICO | 16.97M |
| SkinBioTherapeutics | 14.64M |
| Oxford BioDynamics | 13.44M |
| Palatin Technologies | 12.22M |
| Fusion Antibodies | 12.20M |
| Thalia Therapeutics | 11.10M |
| Genflow Biosciences | 10.20M |
| Solvonis Therapeutics | 7.83M |